Medison Pharma announces multi-regional agreement with argenx to commercialize Efgartigimod
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
States have an important role in ensuring food safety and healthy food practices.
This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo
The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.
To address the preventive & primary healthcare delivery gaps in India
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
Subscribe To Our Newsletter & Stay Updated